New Zealand markets open in 7 hours 41 minutes

MediciNova, Inc. (MNOV)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4400+0.0200 (+1.41%)
As of 10:13AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 70.14M
Enterprise value 23.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)70.14
Price/book (mrq)1.17
Enterprise value/revenue 23.22
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.70
52-week change 3-36.89%
S&P500 52-week change 324.96%
52-week high 32.6600
52-week low 31.2600
50-day moving average 31.3776
200-day moving average 31.5932

Share statistics

Avg vol (3-month) 333.04k
Avg vol (10-day) 346.91k
Shares outstanding 549.05M
Implied shares outstanding 649.05M
Float 842.07M
% held by insiders 12.98%
% held by institutions 120.81%
Shares short (31 May 2024) 4135.6k
Short ratio (31 May 2024) 46.39
Short % of float (31 May 2024) 40.32%
Short % of shares outstanding (31 May 2024) 40.28%
Shares short (prior month 30 Apr 2024) 4212.94k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,007.30%

Management effectiveness

Return on assets (ttm)-9.40%
Return on equity (ttm)-13.18%

Income statement

Revenue (ttm)1M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -10.05M
Net income avi to common (ttm)-8.41M
Diluted EPS (ttm)-0.1700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)47.14M
Total cash per share (mrq)0.96
Total debt (mrq)569.07k
Total debt/equity (mrq)0.95%
Current ratio (mrq)19.07
Book value per share (mrq)1.22

Cash flow statement

Operating cash flow (ttm)-8.12M
Levered free cash flow (ttm)-6M